Endonovo Therapeutics Stock Probability of Future Pink Sheet Price Finishing Over 7.0E-4
| ENDV Stock | USD 0.0006 0.0001 14.29% |
Endonovo |
Endonovo Therapeutics Target Price Odds to finish over 7.0E-4
The tendency of Endonovo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.0007 or more in 90 days |
| 0.0006 | 90 days | 0.0007 | over 95.07 |
Based on a normal probability distribution, the odds of Endonovo Therapeutics to move over $ 0.0007 or more in 90 days from now is over 95.07 (This Endonovo Therapeutics probability density function shows the probability of Endonovo Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Endonovo Therapeutics price to stay between its current price of $ 0.0006 and $ 0.0007 at the end of the 90-day period is under 4.
Given the investment horizon of 90 days Endonovo Therapeutics has a beta of -0.12 suggesting as returns on the benchmark increase, returns on holding Endonovo Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Endonovo Therapeutics is likely to outperform the market. Additionally Endonovo Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Endonovo Therapeutics Price Density |
| Price |
Predictive Modules for Endonovo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Endonovo Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Endonovo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Endonovo Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Endonovo Therapeutics is not an exception. The market had few large corrections towards the Endonovo Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Endonovo Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Endonovo Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.88 | |
β | Beta against Dow Jones | -0.12 | |
σ | Overall volatility | 0.0002 | |
Ir | Information ratio | -0.1 |
Endonovo Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Endonovo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Endonovo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Endonovo Therapeutics generated a negative expected return over the last 90 days | |
| Endonovo Therapeutics has high historical volatility and very poor performance | |
| Endonovo Therapeutics has some characteristics of a very speculative penny stock | |
| Endonovo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 73.11 K. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 58.12 K. | |
| Endonovo Therapeutics currently holds about 59.98 K in cash with (986.58 K) of positive cash flow from operations. | |
| Roughly 25.0% of the company shares are held by company insiders |
Endonovo Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Endonovo Pink Sheet often depends not only on the future outlook of the current and potential Endonovo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Endonovo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.8 M | |
| Cash And Short Term Investments | 85.9 K |
Endonovo Therapeutics Technical Analysis
Endonovo Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Endonovo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Endonovo Therapeutics. In general, you should focus on analyzing Endonovo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Endonovo Therapeutics Predictive Forecast Models
Endonovo Therapeutics' time-series forecasting models is one of many Endonovo Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Endonovo Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Endonovo Therapeutics
Checking the ongoing alerts about Endonovo Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Endonovo Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Endonovo Therapeutics generated a negative expected return over the last 90 days | |
| Endonovo Therapeutics has high historical volatility and very poor performance | |
| Endonovo Therapeutics has some characteristics of a very speculative penny stock | |
| Endonovo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 73.11 K. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 58.12 K. | |
| Endonovo Therapeutics currently holds about 59.98 K in cash with (986.58 K) of positive cash flow from operations. | |
| Roughly 25.0% of the company shares are held by company insiders |
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.